Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 801–900 of 1,000
Circulating Nucleic Acids in Health and Disease
RYKOVA, E. Y., Laktionov, P. P., & Vlassov, V. V. (2010) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-12617-8_7 · Cited by 8
Li, M., Xie, S., Lu, C., Zhu, L., & Zhu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692322 · Cited by 10
Self-citationKoval, A. P., Khromova, A. S., Blagodatskikh, K. А., Zhitnyuk, Y. V., Shtykova, Y. A., Alferov, A. A., Кушлинский, Н. Е., & Shcherbo, D. S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1101179 · Cited by 9
Advances in application of circulating tumor DNA in ovarian cancer
Xia, T., Fang, C., & Chen, Y. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01181-2 · Cited by 10
Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa
Temilola, D. O., Adeola, H. A., Grobbelaar, J., & Chetty, M. (2023) · Cells · doi:10.3390/cells12222663 · Cited by 11
Du, S., Cao, K., Yan, Y., Wang, Y., Wang, Z., & Lin, D. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16416 · Cited by 13
Fu, Y., Jiang, J., Wu, Y., Cao, D., Jia, Z., Zhang, Y., Li, D., Cui, Y., Zhang, Y., & Cao, X. (2024) · Gastric Cancer · doi:10.1007/s10120-024-01493-7 · Cited by 13
The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma
Howell, J. A., & Sharma, R. (2015) · Hepatic Oncology · doi:10.2217/hep.15.38 · Cited by 10
Danstrup, C. S., Marcussen, M., Pedersen, I. S., Jacobsen, H., Dybkær, K., & Gaihede, M. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244101 · Cited by 9
Akahori, D., Inoue, Y., Inui, N., Karayama, M., Yasui, H., Hozumi, H., Suzuki, Y., Furuhashi, K., Fujisawa, T., Enomoto, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94592-9 · Cited by 10
Detection of Circulating Tumor DNA in Patients with Thyroid Nodules
Patel, K., Cormier, N., Fowler, J., Partridge, A., Theurer, J., Black, M. D., Pinto, N. C., Yoo, J. J., Fung, K., MacNeil, S. D., et al. (2021) · International Journal of Endocrinology · doi:10.1155/2021/8909224 · Cited by 10
Jeffers, M., Kappeler, C., Kuss, I., Beckmann, G., Mehnert, D. H., Fredebohm, J., & Teufel, M. (2022) · Gastric Cancer · doi:10.1007/s10120-021-01274-6 · Cited by 11
Zhang, H., Hu, Y., Wang, Y., Song, X., Hu, Y., Ma, L., Yang, X., Li, K., Qin, N., Wang, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.942123 · Cited by 12
Morán, T., Felip, E., Bosch‐Barrera, J., de Aguirre, I., Ramírez, J. L., Mesía, C., Carcereny, E., Roa, D., Sais, È., García, Y. G., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25478 · Cited by 9
Chen, X., Tang, Y., Yan, R., & Miao, P. (2019) · ChemElectroChem · doi:10.1002/celc.201901657 · Cited by 8
Symptoms and diagnosis of local recurrence after rectal cancer treatment
Waldenstedt, S., Haglind, E., & Angenete, E. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2106794 · Cited by 10
Iizuka, R., Tahara, K., Matsueda, A., Tsuda, S., Yoon, D. H., Sekiguchi, T., Shoji, S., & Funatsu, T. (2022) · Biochemical Engineering Journal · doi:10.1016/j.bej.2022.108627 · Cited by 7
Oliveira, B. B., Costa, B. G. L. D. M., Morão, B., Faias, S. R., Veigas, B., Pereira, L. P., Albuquerque, C. M., Maio, R., Cravo, M. L., Fernandes, A. R., et al. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04696-6 · Cited by 10
Fan, W., Ren, W., Jia, D., Shi, J., & Liu, C. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02983 · Cited by 9
Evaluating Stacked Methylation Markers for Blood-Based Multicancer Detection
Funderburk, K. M., Bang-Christensen, S. R., Miller, B., Tan, H., Margolin, G., Petrykowska, H. M., Baugher, C., Farney, S. K., Grimm, S. A., Jameel, N., et al. (2023) · Cancers · doi:10.3390/cancers15194826 · Cited by 7
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Sugawara, T., Lejeune, P., Koehr, S., Neuhaus, R., Faus, H., Gelato, K. A., Busemann, M., Cleve, A., Lücking, U., von Nussbaum, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6864 · Cited by 8
Improving Cancer Detection and Treatment with Liquid Biopsies and ptDNA
Kessler, M. D., Pawar, N. R., Martin, S. S., Antalis, T., & O’Connor, T. D. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.07.004 · Cited by 9
Jagelková, M., Zelinová, K., Laučeková, Z., Bobrovská, M., Daňková, Z., Grendár, M., & Dókuš, K. (2020) · BioResearch open access · doi:10.1089/biores.2019.0031 · Cited by 8
Yang, H., Yan, M., Xu, G., Qian, X., Zhao, R., Han, Y., Zhang, L., Gu, H., & Xu, H. Y. (2021) · Biotechnology Journal · doi:10.1002/biot.202100233 · Cited by 8
Pinheiro, M., Peixoto, A., Rocha, P., Veiga, I., Pinto, C., Santos, C., Pinto, P., Guerra, J., Escudeiro, C., Barbosa, A. P. F., et al. (2022) · International Journal of Colorectal Disease · doi:10.1007/s00384-022-04126-6 · Cited by 9
Noé, J., Bordogna, W., Archer, V. R., Smoljanović, V., Hilton, M., Woodhouse, R., Mocci, S., & Gadgeel, S. M. (2022) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2022.100341 · Cited by 8
Devereaux, K. A., Souers, R. J., Merker, J. D., Lindeman, N. I., Graham, R. P., Hameed, M., Vasalos, P., Moncur, J. T., Lockwood, C. M., & Xian, R. R. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0585-cp · Cited by 8
Valladares‐Ayerbes, M., Alfonso, P. G., Luengo, J. M., Cáceres, P. P., Trujillo, O. A. C., Tocino, R. V., Llanos, M., Ayala, B. L., Mirón, M. L. L., Salud, A., et al. (2022) · Cancers · doi:10.3390/cancers14246075 · Cited by 10
RareVar: A Framework for Detecting Low-Frequency Single-Nucleotide Variants
Hao, Y., Xuei, X., Li, L., Nakshatri, H., Edenberg, H. J., & Liu, Y. (2017) · Journal of Computational Biology · doi:10.1089/cmb.2017.0057 · Cited by 9
The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
Sawada, K., Kotani, D., & Bando, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00263 · Cited by 8
A new era in the detection of urothelial carcinoma by sequencing cell-free DNA
Hayashi, Y., & Fujita, K. (2019) · Translational Andrology and Urology · doi:10.21037/tau.2019.08.26 · Cited by 8
Huang, K., Qu, H., Zhang, X., Huang, T., Sun, X., He, W., Li, M., Lin, L., Xu, M., Chen, S., et al. (2019) · Cancer Biomarkers · doi:10.3233/cbm-190257 · Cited by 9
Self-citationHu, Z.-Y., Tang, Y., Liu, L., Xie, N., Tian, C., Liu, B., Zou, L.-X., Zhou, W., Wang, Y., Xia, X., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101567 · Cited by 9
Verlingue, L., Alt, M., Kamal, M. T., Sablin, M., Zoubir, M., Bousetta, N., Pierga, J., Servant, N., Paolettí, X., & Tourneau, C. L. (2014) · Personalized Medicine · doi:10.2217/pme.14.30 · Cited by 8
Cabezas-Camarero, S., de la Orden, V., García‐Barberán, V., Mediero-Valeros, B., Subhi-Issa, A. I., Llovet, P., Bando, I., Menendez, S. M., Pérez‐Segura, P., & Díaz‐Rubio, E. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0387 · Cited by 10
Plasma derived cell-free mitochondrial DNA originates mainly from circulating cell-free mitochondriaPreprint
Roch, B., Pisareva, E., Sanchez, C., Pastor, B., Tanos, R., Mirandola, A., Mazard, T., Dache, Z. A. A., & Thierry, A. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.03.458846 · Cited by 8
Lygre, K. B., Forthun, R. B., Høysæter, T., Hjelle, S. M., Eide, G. E., Gjertsen, B. T., Pfeffer, F., & Hovland, R. (2024) · BJS Open · doi:10.1093/bjsopen/zrad146 · Cited by 9
Li, L., Huang, Z., Chen, Y., Ma, H., Chen, X., Yan, H., Qin, H., Zhang, Y., Zhang, X. Y., Jiang, W., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40703 · Cited by 9
Azaïs, H., Brochard, C., Taly, V., Benoit, L., Ferron, G., Ray-Coquard, I. L., You, B., Abadie‐Lacourtoisie, S., Lebreton, C., Venat, L., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.12.004 · Cited by 7
LaFramboise, W. A., Petrosko, P., Gallo, P. H., Gil, L., Lam, T. L., Barr, R. M., Schumacher, P. E., Kharoud, H., Taylor, K. M., Dalton, E., et al. (2025) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2025.05.007 · Cited by 8
Wan, J., Saatcioglu, H. D., Ellis, H., Aguado-Fraile, E., Xu, Q., Kondo, H., Manguso, R. T., Gritti, I., Norden, B. L., Noble, C., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-3284 · Cited by 9
Haseltine, J., Offin, M. D., Flynn, J. R., Zhang, Z., Lebow, E. S., Aziz, K., Makhnin, A., Eichholz, J., Lim, L. P., Li, M., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-164 · Cited by 7
Self-citationLiquid biopsy in the management of advanced lung cancer: Implementation and practical aspects
Fernandes, G., Rodrigues, A., Matos, C., Barata, F. J., Cirnes, L., Ferreira, L., Lopes, J. A., Felizardo, M., Fidalgo, P., Brito, U., et al. (2023) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2023.100725 · Cited by 7
Kim, Y. J., & Min, J. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-05025-7 · Cited by 8
Liu, D., Yehia, L., Dhawan, A., Ni, Y., & Eng, C. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101384 · Cited by 8
Mirandola, A., Kudriavtsev, A., Muñoz, C. I. C., Comas, R., Macagno, M., Daoud, S., Sánchez, C., Pastor, B., Pisareva, E., Marin, M. S., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105352 · Cited by 8
Emerging methods in colorectal cancer screening
Ryan, É. J., & Creagh, E. M. (2018) · British journal of surgery · doi:10.1002/bjs.10650 · Cited by 7
Different primers for diagnosing circulating cell-free DNA of colorectal cancer
Shi, H., Li, Q., Liao, J., Bai, L., Wu, S., Xie, J., & He, G. (2020) · Translational Cancer Research · doi:10.21037/tcr-19-2017 · Cited by 6
Park, S., Lee, J.-C., & Choi, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112236 · Cited by 9
Characterization of DNA lesions associated with cell-free DNA by targeted deep sequencing
Shin, S., Park, W., & Park, D. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01040-8 · Cited by 9
Direct Capture and Amplification of Small Fragmented DNAs Using Nitrogen-Mustard-Coated Microbeads
Hapsianto, B. N., Kojima, N., Kurita, R., Yamagata, H., Fujita, H., Fujii, T., & Kim, S. H. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00531 · Cited by 7
Zhang, M., Li, K., Qu, S., Guo, Z., Wang, Y., Yang, X., Zhou, J., Ouyang, G., Weng, R., Li, F., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03735-7 · Cited by 7
Tan, K., Chen, L., Cao, D., Xiao, W., Lv, Q., & Zou, L. (2023) · Analytical Methods · doi:10.1039/d3ay01150j · Cited by 7
Shan, L., Li, M., Ma, J., & Zhang, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107926 · Cited by 8
Self-citationMicrofluidic Droplet Technique for In Vitro Directed Evolution
Wu, N., Oakeshott, J. G., Brown, S., Easton, C. D., & Zhu, Y. (2010) · Australian Journal of Chemistry · doi:10.1071/ch10116 · Cited by 9
Li, L., Zhang, X., Wan, Y., & Jin, W. (2013) · BioMed Research International · doi:10.1155/2013/134675 · Cited by 8
Gall, T., Frampton, A. E., Krell, J., Habib, N., Castellano, L., Stebbing, J., & Jiao, L. R. (2013) · Future Oncology · doi:10.2217/fon.13.152 · Cited by 14
Kalimutho, M., Blanco, G. D. V., Gravina, P., Cretella, M., Mannucci, L., Mannisi, E., Formosa, A., Pallone, F., Federici, G., & Bernardini, S. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.245 · Cited by 7
Govardhan, H., Ahmed, K., Roy, M., Naveen, T., Siddanna, P., Sridhar, P., Suma, M. N., & Nelson, N. (2019) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_551_17 · Cited by 7
Artificial intelligence in hepatocellular carcinoma screening: applications and challenges
Rao, J.-X., Li, Y., & Leng, K. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1713887 · Cited by 9
Martini, G., Napolitano, S., Ciardiello, D., Bielo, L. B., Martinelli, E., Troiani, T., Zampino, M. G., Fazio, N., Curigliano, G., & Ciardiello, F. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01126-1 · Cited by 9
Colorectal cancer: using blood samples and tumor tissue to detectK-rasmutations
Yang, L., Fu, X., Yuan, J.-Q., Yang, Z., Mao, C., Dong, X., Tang, J.-L., & Wang, S. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1037836 · Cited by 6
Xu, M., Shi, T., Xu, R., Chen, G., & He, W. (2023) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2023.05.005 · Cited by 10
Plasma tumor DNA: on your markers, get set, go!
Wong, H. Y., & Park, B. H. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2013.06.07 · Cited by 6
Follow-up tests to detect recurrent disease: Patient's reassurance or medical need?
Smith, I. E., & Schiavon, G. (2013) · The Breast · doi:10.1016/j.breast.2013.07.030 · Cited by 6
Jin, K., Lan, H., Wang, X., & Lv, J. (2017) · PubMed Central · Cited by 7
Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients
Emelyanova, M., Телышева, Е. Н., Орлова, К. В., Ryabaya, O. O., Snigiryova, G. P., Abramov, I. S., & Mikhailovich, V. M. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.11.005 · Cited by 6
Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer
Sun, Y., Zhu, C., Xu, F., Cui, S., & Guan, X. (2023) · Clinical Breast Cancer · doi:10.1016/j.clbc.2023.02.012 · Cited by 7
Hernández-Hernández, S., Guo, Q., & Ballester, P. J. (2025) · Pattern Recognition · doi:10.1016/j.patcog.2025.112501 · Cited by 10
Quasi-digital PCR: Enrichment and quantification of rare DNA variants
Sundberg, S. O., Wittwer, C. T., Zhou, L., Palais, R. A., Dwight, Z., & Gale, B. K. (2014) · Biomedical Microdevices · doi:10.1007/s10544-014-9866-0 · Cited by 7
Digital quantification of gene expression using emulsion PCR
Shi, X., Tang, C., Wang, W., Zhou, D., & Lu, Z. (2010) · Electrophoresis · doi:10.1002/elps.200900362 · Cited by 6
Cheng, C., Wang, J., Yang, C., Zhou, Y., Chen, J., Zhang, J., Jia, N., Cao, H., & Zhao, G. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.10.036 · Cited by 6
Probabilistic modeling methods for cell-free DNA methylation based cancer classification
Halla-aho, V., & Lähdesmäki, H. J. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04651-9 · Cited by 7
Heitzer, E., Mohan, S., Ulz, P., Lafer, I., Auer, M., Lax, S., Höefler, G., Bauernhofer, T., Geigl, J. B., & Speicher, M. R. (2014) · European Journal of Cancer · doi:10.1016/s0959-8049(14)50357-7 · Cited by 6
Chen, S., Tsai, H., Jiang, J., Sung, Y.-C., Huang, C.-W., Yeh, Y., Chen, L., & Wang, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5826-7 · Cited by 6
Liquid Biopsy im kolorektalen Karzinom
Haupts, A., Roth, W., & Hartmann, N. (2019) · Der Pathologe · doi:10.1007/s00292-019-00698-3 · Cited by 8
Circulating nucleic acids and protease activities in blood of tumor patients
Schwarzenbach, H. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.674508 · Cited by 6
Liquid Biopsy for Colorectal Cancer: Advancing Detection and Clinical Application
Li, Y., Zhang, Q., & Cook, S. M. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5020014 · Cited by 6
Guo, C., Zhang, J., Zhang, S., Moon, J., Yang, R., Guan, X., Hou, C., Pei, M., Schalper, K. T., Schreiber, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66893-4 · Cited by 7
Kudriavtsev, A., Pastor, B., Mirandola, A., Pisareva, E., Gricourt, Y., Capdevila, X., Thierry, A. R., & Cuvillon, P. (2024) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbae008 · Cited by 5
Nam, H., Lee, E. Y., Yang, H., Lee, K., kwak, T., Kim, D., Kim, H. M., Yang, M., Yang, Y., Son, S., et al. (2024) · Biology Methods and Protocols · doi:10.1093/biomethods/bpae041 · Cited by 6
Pham, T. T., Lim, S. H.-S., & Lin, M. F. (2022) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2022.2114457 · Cited by 6
Fan, W., Ren, W., & Liu, C. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04395-8 · Cited by 5
Barthélémy, D., Lescuyer, G., Geiguer, F., Grolleau, E., Gauthier, A., Balandier, J., Raffin, M., Bardel, C., Bouyssounouse, B., Rodriguez‐Lafrasse, C., et al. (2023) · Cancers · doi:10.3390/cancers15051574 · Cited by 7
Dahl, E., Jung, A., Fassunke, J., Hummel, M., Penzel, R., Dietmaier, W., & Laßmann, S. (2014) · Der Pathologe · doi:10.1007/s00292-014-2069-x · Cited by 7
Statistical modeling for sensitive detection of low-frequency single nucleotide variants
Hao, Y., Zhang, P., Xuei, X., Nakshatri, H., Edenberg, H. J., Li, L., & Liu, Y. (2016) · BMC Genomics · doi:10.1186/s12864-016-2905-x · Cited by 5
„Liquid biopsy“: Analyse molekularer Marker aus Blutproben zur Therapiesteuerung beim Lungenkarzinom
Brueckl, W. M., Wirtz, R. M., Bertsch, T., Ficker, J. H., & Jung, A. (2017) · Pneumologie · doi:10.1055/s-0042-123803 · Cited by 6
Vietsch, E. E., Graham, G. T., McCutcheon, J. N., Javaid, A., Giaccone, G., Marshall, J. L., & Wellstein, A. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.11.001 · Cited by 5
Koba, H., Kimura, H., Yoneda, T., Sone, T., Ohkura, N., Hara, J., Hosomichi, K., Tajima, A., & Kasahara, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-87094-1 · Cited by 6
Comparison of circulating DNA in malignant neoplasia from diverse locations
Kumari, S., Mishra, S., Husain, N., Verma, T., Tiwari, V., Kaif, M., Agarwal, A., Rastogi, M., Shukla, S., & Sonkar, A. A. (2022) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_474_20 · Cited by 5
Martínez-Gregorio, H., Díaz-Velásquez, C. E., Romero-Piña, M., la Cruz, M. R.-D., Delgado‐Buenrostro, N. L., Cruz-Montoya, A. H. D. L., Chirino, Y. I., Terrazas, L. I., Medina, L. A., & Vaca‐Paniagua, F. (2022) · Journal of Cancer · doi:10.7150/jca.76516 · Cited by 5
Emerging frontiers of cell-free DNA fragmentomics
Hu, X., Ding, S. C., & Jiang, P. (2022) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2022.34 · Cited by 8
Ray-Coquard, I. L., Chauvin, F., Leblanc, É., Caux, C., Hoarau, H., Bonnetain, F., Christophe, V., Sastre‐Garau, X., Lazennec, G., Poulain, L., et al. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2012.1558 · Cited by 5
10. Circulating Nucleic Acids as Diagnostic Tool.
Ferrari, M., Cremonesi, L., & Galbiati, S. (2008) · PubMed Central · Cited by 5
Malone, M. L., Cavett, V. J., & Paegel, B. M. (2016) · ACS Combinatorial Science · doi:10.1021/acscombsci.6b00146 · Cited by 5
Barták, B. K., Márkus, E., Kalmár, A., Galamb, O., Szigeti, K. A., Nagy, Z. B., Zsigrai, S., Tulassay, Z., Dank, M., Igaz, P., et al. (2019) · Orvosi Hetilap · doi:10.1556/650.2019.31486 · Cited by 5
Billaud, A., Verrièle, V., Dauvé, J., Chevalier, L.-M., & Morel, A. (2020) · Diagnostics · doi:10.3390/diagnostics10080527 · Cited by 6
Tracking tumour evolution through liquid biopsy
Turajlic, S., & Swanton, C. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.153 · Cited by 5
Wank, R., Song, X., Gu, S., & Laumbacher, B. (2014) · Immunotherapy · doi:10.2217/imt.14.6 · Cited by 5
Detection of rare point mutation via allele-specific amplification in emulsion PCR
Cheng, C., Zhou, Y., Yang, C., Chen, J., Wang, J., Zhang, J., & Zhao, G. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.5.155 · Cited by 5
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.